Trial Profile
A phase I study of Trapine [OCX 0191] in combination with irinotecan in refractory tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- 18 Jan 2007 Status changed from recruiting
- 12 Sep 2005 New trial record.